Seven Eight Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-169,612
| Closed | -$1.05M | – | 719 |
|
|
2024
Q2 | $1.05M | Buy |
169,612
+158,358
| +1,407% | +$979K | 0.11% | 345 |
|
|
2024
Q1 | $57.2K | Buy |
+11,254
| New | +$57.2K | 0.01% | 582 |
|
|
2022
Q4 | – | Sell |
-20,330
| Closed | -$256K | – | 418 |
|
|
2022
Q3 | $256K | Buy |
+20,330
| New | +$256K | 0.05% | 412 |
|
|
2021
Q4 | – | Sell |
-50,132
| Closed | -$720K | – | 465 |
|
|
2021
Q3 | $720K | Buy |
50,132
+6,736
| +16% | +$96.7K | 0.07% | 363 |
|
|
2021
Q2 | $686K | Buy |
43,396
+11,596
| +36% | +$183K | 0.1% | 355 |
|
|
2021
Q1 | $237K | Hold |
31,800
| – | – | 0.05% | 353 |
|
|
2020
Q4 | $237K | Buy |
+31,800
| New | +$237K | 0.05% | 358 |
|